Balyasny Asset Management LLC Morpho Sys Ag Transaction History

Balyasny Asset Management LLC

  • $54.9 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$8.6 - $18.18 $10.9 Million - $23.1 Million
1,272,343 Added 4026.15%
1,303,945 $23.7 Million
Q4 2023

Feb 14, 2024
BUY
$4.55 - $9.9 $143,789 - $312,859
31,602 New
31,602 $312,000

Others Institutions Holding MOR

# of Institutions
43
Shares Held
1.84M
Call Options Held
79.8K
Put Options Held
688K
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email